1-3 of 3
Lierni Fernández-Ibarrondo
Close
Sort by
Journal Articles

Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy

Juan Jose Rodríguez-Sevilla, Concepción Fernández-Rodríguez, Leyre Bento, Ramón Diez-Feijóo, Sergio Pinzón, Joan Gibert, Lierni Fernández-Ibarrondo, Marta Lafuente, Ana Ferrer, Blanca Sánchez-González, Eva Gimeno, Juan Sainz, Rafael Ramos, Juan F. García, Lluis Colomo, Beatriz Bellosillo, Antonio Gutiérrez, Antonio Salar
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1606–1614.
https://doi.org/10.1182/bloodadvances.2022007949
Published: 2023
Includes: Supplemental data
Journal Articles

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA

Nieves Garcia-Gisbert, Sara Garcia-Ávila, Brayan Merchán, Marta Salido, Concepción Fernández-Rodríguez, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Marta Lafuente, Raquel Longarón, Blanca Espinet, Patricia Vélez, Ramon M. Pujol, Marcio Andrade-Campos, Leonor Arenillas, Antonio Salar, Xavier Calvo, Carles Besses, Beatriz Bellosillo
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3178–3188.
https://doi.org/10.1182/bloodadvances.2021006565
Published: 2022
Includes: Supplemental data
Journal Articles

Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity

Concepción Fernández-Rodríguez, Juan José Rodríguez-Sevilla, Lierni Fernández-Ibarrondo, Blanca Sánchez-González, Joan Gibert, Leire Bento, Juan Fernando García, Juan Manuel Sancho, Ramón Diez-Feijóo, Laura Camacho, Montserrat García-Retortillo, Eva Gimeno, Luis Colomo, Antonio Gutiérrez, Beatriz Bellosillo, Antonio Salar
Journal: Blood Advances
Blood Adv (2022) 6 (1): 82–86.
https://doi.org/10.1182/bloodadvances.2021005316
Published: 2022
Includes: Supplemental data